Interestingly, Smad4 was found to be overexpressed in most extrahepatic cholangiocarcinoma patients [33], whereas the inactivation of Smad4 was identified in intrahepatic cholangiocarcinoma [34], which might be due to tumor heterogeneity. The gene discussed is SMAD4; the disease is neoplasm.